Taylor Wealth Management Partners Biom X Inc. Transaction History

Taylor Wealth Management Partners

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$14.4 - $30.4 $366,537 - $773,801	-25,454 Closed	0 $0
Q3 2021 Oct 26, 2021	SELL	$30.6 - $58.1 $194,310 - $368,935	-6,350 Reduced 19.97%	25,454 $78,000
Q2 2021 Aug 11, 2021	SELL	$52.6 - $72.5 $57,860 - $79,750	-1,100 Reduced 3.34%	31,804 $174,000
Q1 2021 Apr 21, 2021	SELL	$63.1 - $86.4 $369,008 - $505,267	-5,848 Reduced 15.09%	32,904 $234,000
Q4 2020 Feb 02, 2021	SELL	$56.0 - $66.7 $268,800 - $320,160	-4,800 Reduced 11.02%	38,752 $247,000
Q2 2020 Jul 27, 2020	SELL	$47.1 - $78.0 $357,489 - $592,020	-7,590 Reduced 14.84%	43,552 $240,000
Q1 2020 May 04, 2020	BUY	$61.2 - $104.4 $38,188 - $65,145	624 Added 1.24%	51,142 $358,000
Q4 2019 Jan 30, 2020	BUY	$61.3 - $108.0 $3.1 Million - $5.46 Million	50,518 New	50,518 $489,000

301K

Ticker PHGE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,982,300
Market Cap $21.9M
Description
BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibr...

Get notified when there are updates to the investment portfolio of Taylor Wealth Management Partners, based on Form 13F filings with the SEC.

Stay updated on Taylor Wealth Management Partners with notifications on news.